{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:13:43Z","timestamp":1791317623792,"version":"4.3.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>EDP1815 is a non-colonizing pharmaceutical preparation of a single stain of <jats:italic>Prevotella histicola<\/jats:italic> isolated from the duodenum of a human donor. We report here preclinical and clinical studies showing that the action of EDP1815, an orally delivered and gut restricted single strain of commensal bacteria can regulate inflammatory responses throughout the body.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Supported by evidence for anti-inflammatory activity in three preclinical mouse models of Th1-, TH2-, and Th17-mediated inflammation, EDP1815 was tested clinically in three Phase 1b studies in patients with psoriasis, patients with atopic dermatitis, and healthy volunteers in a KLH skin challenge model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Preclinically, EDP1815 was efficacious in all three mouse models of inflammation, showing reduction in skin inflammation as well as related tissue cytokines. In the Phase 1b studies, EDP1815 was found to be well tolerated by participants, with a safety profile comparable to placebo, including no severe or consistent side-effects reported, and no evidence of immunosuppression with no opportunistic infection occurring in these studies. In psoriasis patients, signs of clinical efficacy were seen after 4 weeks of treatment, which continued beyond the treatment period in the higher-dose cohort. In atopic dermatitis patients, improvements were seen throughout the key physician-and patient-reported outcomes. In a healthy-volunteer study of a KLH-induced skin inflammatory response, consistent anti-inflammatory effects were seen in two cohorts through imaging-based measures of skin inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This is the first report demonstrating clinical effects from targeting peripheral inflammation with a non-colonizing gut-restricted single strain of commensal bacteria, providing proof of concept for a new class of medicines. These clinical effects occur without systemic exposure of EDP1815 or modification of the resident gut microbiota, and with placebo-like safety and tolerability. The breadth of these clinical effects of EDP1815, combined with its excellent safety and tolerability profile and oral administration, suggests the potential for a new type of effective, safe, oral, and accessible anti-inflammatory medicine to treat the wide range of diseases driven by inflammation.<\/jats:p><jats:p><jats:bold>Clinical Trial Registration<\/jats:bold>: EudraCT # 2018-002807-32; EudraCT # 2018-002807-32; NL8676; <jats:ext-link>https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03733353<\/jats:ext-link>; <jats:ext-link>http:\/\/www.trialregister.nl<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1070433","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T13:19:12Z","timestamp":1683292752000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical translation of anti-inflammatory effects of Prevotella histicola in Th1, Th2, and Th17 inflammation"],"prefix":"10.3389","volume":"10","author":[{"given":"Andrea","family":"Itano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Maslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritika","family":"Ramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golbarg","family":"Mehraei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Cormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Saghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Moerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Troy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Caffry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Wardwell-Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"McHale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1111\/j.1462-2920.2010.02294.x","article-title":"High temporal and inter-individual variation detected in the human ileal microbiota","volume":"12","author":"Booijink","year":"2010","journal-title":"Environ Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jcmgh.2019.07.006","article-title":"The structure and function of the human small intestinal microbiota: current understanding and future directions","volume":"9","author":"Kastl","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"768076","DOI":"10.3389\/fimmu.2022.768076","article-title":"Regulation of peripheral inflammation by a non-viable, non-colonizing strain of commensal bacteria","volume":"13","author":"Ramani","year":"2022","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/s41467-019-09884-6","article-title":"Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis","volume":"10","author":"Ramakrishna","year":"2019","journal-title":"Nat Commun"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/glycob\/cwx093","article-title":"Polysaccharide-experienced effector T cells induce IL-10 in FoxP3+ regulatory T cells to prevent pulmonary inflammation","volume":"28","author":"Johnson","year":"2018","journal-title":"Glycobiology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41579-021-00559-y","article-title":"Prevotella diversity, niches and interactions with the human host","volume":"19","author":"Tett","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature24460","article-title":"Quantitative microbiome profiling links gut community variation to microbial load","volume":"551","author":"Vandeputte","year":"2017","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1002\/art.39785","article-title":"Suppression of inflammatory arthritis by human gut-derived Prevotella histicola in humanized mice","volume":"68","author":"Marietta","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.celrep.2017.07.031","article-title":"Human gut-derived commensal bacteria suppress CNS inflammatory and demyelinating disease","volume":"20","author":"Mangalam","year":"2017","journal-title":"Cell Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"102237","DOI":"10.1016\/j.anaerobe.2020.102237","article-title":"Human gut-derived commensal suppresses generation of T-cell response to gliadin in humanized mice by modulating gut microbiota","volume":"68","author":"Bodkhe","year":"2021","journal-title":"Anaerobe"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0188475","DOI":"10.1371\/journal.pone.0188475","article-title":"Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study","volume":"12","author":"de Groot","year":"2017","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.0019-2805.2004.01818.x","article-title":"Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-gamma via CXCR3 chemokines","volume":"111","author":"Akahira-Azuma","year":"2004","journal-title":"Immunology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1365-2222.2008.03177.x","article-title":"T helper 2 biased de novo immune response to keyhole limpet Hemocyanin in humans","volume":"39","author":"Spazierer","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1111\/bcp.14588","article-title":"A randomized controlled trial with a delayed-type hypersensitivity model using keyhole limpet haemocyanin to evaluate adaptive immune responses in man","volume":"87","author":"Saghari","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/bcp.12422","article-title":"Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies","volume":"78","author":"Swaminathan","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/cpt.2539","article-title":"OX40L inhibition suppresses KLH-driven immune responses in healthy volunteers: A randomized controlled trial demonstrating proof-of-pharmacology for KY1005","volume":"111","author":"Saghari","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00011-016-0923-4","article-title":"Characterization of the clinical and activated T cell response to repeat delayed-type hypersensitivity skin challenges in human subjects, with KLH and PPD, as a potential model to test T cell-targeted therapies","volume":"65","author":"Belson","year":"2016","journal-title":"Inflamm Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/jid.2010.251","article-title":"Eczema prevalence in the United States: data from the 2003 National Survey of Children\u2019s health","volume":"131","author":"Shaw","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5021\/ad.2010.22.2.125","article-title":"Atopic dermatitis","volume":"22","author":"Bieber","year":"2010","journal-title":"Ann Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3390\/ijms21082867","article-title":"Skin barrier abnormalities and immune dysfunction in atopic dermatitis","volume":"21","author":"Yang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4172\/2155-9899.1000110","article-title":"Th2 cytokines and atopic dermatitis","volume":"2","author":"Brandt","year":"2011","journal-title":"J Clin Cell Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1080\/09546634.2021.1986204","article-title":"Efficacy of biologics and oral small molecules for atopic dermatitis: a systematic review and meta-analysis","volume":"33","author":"Nusbaum","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.jaci.2011.01.054","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts","volume":"127","author":"Guttman-Yassky","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaci.2011.01.053","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts","volume":"127","author":"Guttman-Yassky","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"Global psoriasis, national, regional, and worldwide epidemiology of psoriasis: systematic analysis and modeling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on psoriasis immunopathogenesis and targeted immunotherapy","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin Immunopathol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"11736","DOI":"10.1073\/pnas.0604575103","article-title":"Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis","volume":"103","author":"Li","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1398-9995.2011.02719.x","article-title":"EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference","volume":"67","author":"Schram","year":"2012","journal-title":"Allergy"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000365390","article-title":"Determining the minimal clinically important difference and responsiveness of the dermatology life quality index (DLQI): further data","volume":"230","author":"Basra","year":"2015","journal-title":"Dermatology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","article-title":"Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system Physician\u2019s global assessment","volume":"51","author":"Langley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12866-021-02406-9","article-title":"Administration of Human Derived Upper gut commensal Prevotella histicola delays the onset of type 1 diabetes in NOD mice","volume":"22","author":"Marietta","year":"2022","journal-title":"BMC Microbiol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1177\/0091270011427908","article-title":"Pharmacodynamic effects of steady-state fingolimod on antibody response in healthy volunteers: a 4-week, randomized, placebo-controlled, parallel-group, multiple-dose study","volume":"52","author":"Boulton","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0889-1591(03)00107-7","article-title":"The relationship between distress and the development of a primary immune response to a novel antigen","volume":"18","author":"Smith","year":"2004","journal-title":"Brain Behav Immun"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/01.psy.0000130962.28801.af","article-title":"Influences of distress and alcohol consumption on the development of a delayed-type hypersensitivity skin test response","volume":"66","author":"Smith","year":"2004","journal-title":"Psychosom Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1152\/japplphysiol.01404.2003","article-title":"Influence of age and physical activity on the primary in vivo antibody and T cell-mediated responses in men","volume":"97","author":"Smith","year":"2004","journal-title":"J Appl Physiol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1365-2249.2004.02447.x","article-title":"Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine","volume":"136","author":"Boelens","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","article-title":"Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms","volume":"6","author":"Caporaso","year":"2012","journal-title":"ISME J"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"027607","DOI":"10.1101\/027607","article-title":"One codex: A sensitive and accurate data platform for genomic microbial identification","author":"Minot","year":"2015","journal-title":"BioRxiv"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.gpb.2015.02.005","article-title":"Metagenomic surveys of gut microbiota","volume":"13","author":"Mandal","year":"2015","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"ref44","first-page":"51","article-title":"Data structures for statistical computing in python","author":"McKinney","year":"2010"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput Sci Eng"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.883859","article-title":"mwaskom\/seaborn: v0.8.1","volume":"2017","author":"Waskom","year":"2017","journal-title":"Zenodo"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1070433\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T13:19:16Z","timestamp":1683292756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1070433\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":46,"alternative-id":["10.3389\/fmed.2023.1070433"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1070433","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"article-number":"1070433"}}